LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414,406 | -28.8% | 6,916 | -14.4% | 0.00% | – |
| Q2 2023 | $582,207 | +570.2% | 8,075 | +583.7% | 0.00% | – |
| Q1 2023 | $86,875 | -21.7% | 1,181 | -28.9% | 0.00% | – |
| Q4 2022 | $110,888 | +257.7% | 1,660 | +361.1% | 0.00% | – |
| Q3 2022 | $31,000 | -48.3% | 360 | -46.3% | 0.00% | – |
| Q2 2022 | $60,000 | -98.3% | 670 | -97.9% | 0.00% | -100.0% |
| Q1 2022 | $3,520,000 | -15.2% | 31,284 | +16.4% | 0.00% | 0.0% |
| Q4 2021 | $4,150,000 | +10.6% | 26,868 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $3,753,000 | +53.6% | 26,942 | +44.7% | 0.00% | – |
| Q2 2021 | $2,443,000 | -83.3% | 18,623 | -80.6% | 0.00% | -100.0% |
| Q1 2021 | $14,644,000 | +281.3% | 96,054 | +148.7% | 0.01% | +400.0% |
| Q4 2020 | $3,841,000 | +301.8% | 38,621 | +285.3% | 0.00% | – |
| Q3 2020 | $956,000 | +12.7% | 10,024 | +32.3% | 0.00% | – |
| Q2 2020 | $848,000 | -21.4% | 7,579 | -48.9% | 0.00% | – |
| Q1 2020 | $1,079,000 | -85.8% | 14,838 | -79.7% | 0.00% | -100.0% |
| Q4 2019 | $7,617,000 | +15.2% | 73,040 | +9.9% | 0.00% | -33.3% |
| Q3 2019 | $6,614,000 | +417.5% | 66,452 | +493.6% | 0.00% | – |
| Q2 2019 | $1,278,000 | -71.2% | 11,195 | -68.3% | 0.00% | -100.0% |
| Q1 2019 | $4,444,000 | -29.4% | 35,352 | -23.8% | 0.00% | -33.3% |
| Q4 2018 | $6,297,000 | -40.4% | 46,408 | +20.6% | 0.00% | -25.0% |
| Q3 2018 | $10,564,000 | +160.3% | 38,487 | +96.5% | 0.00% | +100.0% |
| Q2 2018 | $4,058,000 | -60.5% | 19,588 | -68.5% | 0.00% | -50.0% |
| Q1 2018 | $10,265,000 | +582.1% | 62,154 | +465.7% | 0.00% | +300.0% |
| Q4 2017 | $1,505,000 | -59.4% | 10,988 | -59.6% | 0.00% | -50.0% |
| Q3 2017 | $3,704,000 | -21.8% | 27,201 | -30.3% | 0.00% | 0.0% |
| Q2 2017 | $4,739,000 | +138.4% | 39,039 | +107.9% | 0.00% | +100.0% |
| Q1 2017 | $1,988,000 | -65.4% | 18,781 | -66.8% | 0.00% | -66.7% |
| Q4 2016 | $5,743,000 | +97.0% | 56,524 | +97.9% | 0.00% | +50.0% |
| Q3 2016 | $2,915,000 | -47.6% | 28,562 | -38.8% | 0.00% | -33.3% |
| Q2 2016 | $5,567,000 | +328.9% | 46,678 | +285.2% | 0.00% | +200.0% |
| Q1 2016 | $1,298,000 | -82.1% | 12,118 | -81.9% | 0.00% | -80.0% |
| Q4 2015 | $7,250,000 | +160.0% | 66,862 | +105.5% | 0.01% | +150.0% |
| Q3 2015 | $2,788,000 | +10.3% | 32,538 | +29.9% | 0.00% | 0.0% |
| Q2 2015 | $2,528,000 | +42.3% | 25,051 | +8.7% | 0.00% | +100.0% |
| Q1 2015 | $1,777,000 | +287.1% | 23,048 | +167.6% | 0.00% | – |
| Q4 2014 | $459,000 | – | 8,613 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |